Disciplined Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-5
| Closed | -$950 | – | 167 |
|
2023
Q2 | $950 | Buy |
5
+2
| +67% | +$380 | ﹤0.01% | 990 |
|
2023
Q1 | $601 | Sell |
3
-1
| -25% | -$200 | ﹤0.01% | 1172 |
|
2022
Q4 | $951 | Sell |
4
-1
| -20% | -$238 | ﹤0.01% | 926 |
|
2022
Q3 | $1K | Buy |
5
+3
| +150% | +$600 | ﹤0.01% | 768 |
|
2022
Q2 | $0 | Sell |
2
-1
| -33% | – | ﹤0.01% | 1237 |
|
2022
Q1 | $0 | Buy |
+3
| New | – | ﹤0.01% | 1317 |
|